Evidence map›Paper›PMID 37738885›Full record

ArticlePediatric neurology2023

Genetic Neuromuscular Disorders and Health Services Access, Utilization, and Needs in Zambia.

Musambo M Kapapa, David R Bearden, Somwe Wa Somwe, Gretchen L Birbeck, Gita Ramdharry, ICGNMD Consortium, Michelle Kvalsund

Abstract read
In one paragraph

Article in Pediatric neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Musambo M KapapaUniversity Teaching Hospital Neurology Research Office, Lusaka, Zambia.
David R BeardenUniversity Teaching Hospital Neurology Research Office, Lusaka, Zambia; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
Somwe Wa SomweUniversity Teaching Hospital Neurology Research Office, Lusaka, Zambia.
Gretchen L BirbeckUniversity Teaching Hospital Neurology Research Office, Lusaka, Zambia; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
Gita RamdharryCentre for Neuromuscular Diseases, London, UK.
ICGNMD Consortium
Michelle KvalsundUniversity Teaching Hospital Neurology Research Office, Lusaka, Zambia; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia. Electronic address: Michelle_Kvalsund@urmc.rochester.edu.

Funding

Longitudinal Cognitive Outcomes in Children and Adolescents with HIV in ZambiaK23NS117310 · NINDS · UNIVERSITY OF ROCHESTER · PI BEARDEN, DAVID ROSS · 2020 to 2024
$1.0M
Community Health and Neuropathy: Nutritional and Environmental Links in Zambia (CHANNELZ)K23NS112463 · NINDS · UNIVERSITY OF ROCHESTER · PI KVALSUND, MICHELLE POWELL · 2020 to 2024
$925k
NINDS NIH HHS K23 NS112463NINDS NIH HHS K23 NS117310
6 · The paper itself

Abstract

backgroundMedical and rehabilitative advances increasingly transform management of rare genetic neuromuscular diseases (GNMDs) for children in the global north. Lack of information about GNMDs and related health care needs in sub-Saharan Africa threatens to widen pre-existing health disparities.

methodsThis is a cross-sectional study of probands enrolling in a study of GNMDs at the University Teaching Hospital in Lusaka, Zambia, a member of the International Consortium for Genomic Medicine in Neuromuscular Disease. Probands/caregivers were interviewed about utilization of medical, rehabilitative, and other support services by a research assistant. A neuromuscular neurologist and/or physiotherapist examined each case and completed an independent questionnaire regarding health service utilization for each proband. Diagnoses were made on available clinical and electrophysiologic data. Molecular findings were unavailable at the time of this analysis.

resultsAmong 50 probands, 52% were male with median age 12 (absolute range 2 months to 54 years). Motor neuron diseases (n = 16; 32%), muscle disorders (n = 20; 40%), and inherited polyneuropathies (n = 5; 10%) were most common. Six (15%) cases had insufficient clinical data to classify the GNMDs. Outside of primary care, patient/caregiver-reported access to recommended health services (n = 34; 69%) was challenging. Large disparities in current utilization of health care services versus clinician-recommended services are reported.

conclusionsParadigms to improve access to diagnostics and therapeutic interventions are needed for GNMDs in Zambia. Multidisciplinary clinics may improve access and utilization of needed health services. Qualitative and other research focused on improving referrals, access, and quality of available health services are greatly needed.

Indexed as

CaregiversNeuromuscular DiseasesChildCross-Sectional StudiesFemaleHealth ServicesHumansInfantMaleZambiaAfricaGeneticHealth servicesNeuromuscular diseaseRehabilitation

Identifiers

PMID37738885
PMCPMC10642628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.